Clinical Trial Update: A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma [Phase 1]

View source ↗

Summary

A Phase 1 pediatric trial of SurVaxM for progressive or relapsed medulloblastoma, high-grade glioma, ependymoma, and newly diagnosed diffuse intrinsic pontine g…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Anaplastic Ependymoma
• Anaplastic Oligodendroglioma
• Diffuse Intrinsic Pontine Glioma
• Ependymoma
• Glioblastoma
• High-grade Astrocytoma
• Medulloblastoma

Drugs mentioned

• SurVaxM (SurVaxM)

Snippet

Sponsor: Children's Oncology Group | Conditions: Medulloblastoma, Glioblastoma Multiforme | Phase 1 | Status: ACTIVE_NOT_RECRUITING